SCHEMBL23745324

SCHEMBL23745324

CC1CN(C(=O)C(F)(F)F)CCc2cc(Cl)c(Cl)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.45
ESR2 Q92731 8/20 0.45
HTR2A P28223 3/20 0.41
HTR2C P28335 3/20 0.41
HTR2B P41595 3/20 0.41
DRD1 P21728 6/20 0.38
DRD2 P14416 3/20 0.38
DRD5 P21918 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 1/20 0.38
NFKB1 P19838 1/20 0.38
THPO P40225 1/20 0.38
MEN1 O00255 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
ABHD6 Q9BV23 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31121185 1.00 ESR1 (0.45) ESR1ESR2HTR2AHTR2CHTR2B
SCHEMBL30012797 0.91 HTR2A (0.47) ESR1ESR2HTR2AHTR2CHTR2B
SCHEMBL1095022 0.91 ESR1 (0.45) ESR1ESR2DRD1DRD2DRD5
SCHEMBL1094863 0.91 HTR2A (0.47) ESR1ESR2HTR2AHTR2CHTR2B
SCHEMBL4938554 0.90 ESR1 (0.41) ESR1ESR2DRD1DRD2DRD5
SCHEMBL1094406 0.88 HTR2A (0.48) ESR1ESR2HTR2AHTR2CHTR2B
SCHEMBL31121204 0.85 ESR1 (0.49) ESR1ESR2HTR2AHTR2CHTR2B
SCHEMBL3282297 0.85 ESR1 (0.49) ESR1ESR2HTR2AHTR2CHTR2B
SCHEMBL3282323 0.85 ESR1 (0.49) ESR1ESR2HTR2AHTR2CHTR2B
SCHEMBL1095555 0.85 ESR1 (0.49) ESR1ESR2HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021158626-A1 ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF Eternity Bioscience Inc. (US) 2021-08-12 WO disclosed